Danielle Gabrish

Director, Clinical Biologics
Danielle Gabrish, currently a Director of Clinical Biologics within the Biopharmaceutical Development Organization has been with AstraZeneca for over 16 years. Throughout her career, Danielle has demonstrated a deep understanding of the pharmaceutical industry and has been instrumental in ensuring the safety and effectiveness of products. Prior to her current role, she held roles within Technical Operations Validation, Manufacturing Sciences and Technology Process Validation, and Manufacturing at the Commercial Manufacturing Site. Her leadership skills have allowed her to effectively build high performing diverse teams. She is a subject matter expert in regulatory agency interactions. Danielle drives lean maturity and prioritization of strategic visions for site and global initiatives, focusing on supply chain capabilities, building plant capacity, and talent development. Danielle holds a triplicate bachelor's degree in Microbiology, Bioinformatics, and Biochemistry from Towson University. product facility startups and product licensure. Subject matter expert in regulatory agency interactions. Drives lean maturity and strategic vision prioritization of site and global initiatives with a focus on supply chain capabilities and building plant capacity.